The Interplay of Akt and ERK in Aβ Toxicity and Insulin-Mediated Protection in Primary Hippocampal Cell Culture

Journal of Molecular Neuroscience

Volumn 57, Issue 3, 2015, Pages 325-334

  Ghasemi, Rasoul ^a   Moosavi, Maryam ^b,d   Zarifkar, Asadollah ^b   Rastegar, Karim ^b   maghsoudi, Nader ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Akt; Alzheimer s disease; Beta amyloid; Caspase 3; ERK; Hippocampal cell culture

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; AMYLOID BETA PROTEIN[25-35]; CASPASE 3; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (25-35); CHROMONE DERIVATIVE; FLAVONOID; MORPHOLINE DERIVATIVE; NERVE PROTEIN; NEUROPROTECTIVE AGENT; PEPTIDE FRAGMENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE INHIBITOR;

APOPTOSIS; ARTICLE; BRAIN CELL CULTURE; BRAIN PROTECTION; CELL DEATH; CELL DIFFERENTIATION; CELL STRUCTURE; DRUG EFFECT; EMBRYO DEVELOPMENT; FETUS; HIPPOCAMPUS; HUMAN; HUMAN CELL; INSULIN TREATMENT; INTRACELLULAR SIGNALING; NEUROTOXICITY; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PRIMARY CELL CULTURE; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; CASPASE 3; CELLS, CULTURED; CHROMONES; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; HIPPOCAMPUS; INSULIN; MAP KINASE SIGNALING SYSTEM; MORPHOLINES; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 84944274255     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-015-0622-6     Document Type: Article

References (43)

1. Behl C, Davis JB, Klier FG, Schubert D (1994) Amyloid beta peptide induces necrosis rather than apoptosis. Brain Res 645(1–2):253–264
2. Bogoyevitch MA, Court NW (2004) Counting on mitogen-activated protein kinases—ERKs 3, 4, 5, 6, 7 and 8. Cell Signal 16(12):1345–1354
3. Chen K, Iribarren P, Hu J, Chen J, Gong W, Cho EH, Lockett S, Dunlop NM, Wang JM (2006) Activation of toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid beta peptide. J Biol Chem 281(6):3651–3659
4. Cho HJ, Kim SK, Jin SM, Hwang EM, Kim YS, Huh K, Mook-Jung I (2007) IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes. Glia 55(3):253–262
5. Chong YH, Shin YJ, Lee EO, Kayed R, Glabe CG, Tenner AJ (2006) ERK1/2 activation mediates Abeta oligomer-induced neurotoxicity via caspase-3 activation and tau cleavage in rat organotypic hippocampal slice cultures. J Biol Chem 281(29):20315–20325
6. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B (2012) Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol 69(1):29–38
7. Cui W, Tao J, Wang Z, Ren M, Zhang Y, Sun Y, Peng Y, Li R (2013) Neuregulin1beta1 antagonizes apoptosis via ErbB4-dependent activation of PI3-kinase/Akt in APP/PS1 transgenic mice. Neurochem Res 38(11):2237–2246
8. Datta SR, Brunet A, Greenberg ME (1999) Cellular survival: a play in three Akts. Genes Dev 13(22):2905–2927
9. De Fea K, Roth RA (1997) Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J Biol Chem 272(50):31400–31406
10. Dehvari N, Isacsson O, Winblad B, Cedazo-Minguez A, Cowburn RF (2008) Presenilin regulates extracellular regulated kinase (ERK) activity by a protein kinase C alpha dependent mechanism. Neurosci Lett 436(1):77–80
11. Engelman JA, Berg AH, Lewis RY, Lisanti MP, Scherer PE (2000) Tumor necrosis factor alpha-mediated insulin resistance, but not dedifferentiation, is abrogated by MEK1/2 inhibitors in 3T3-L1 adipocytes. Mol Endocrinol 14(10):1557–1569
12. Feng CQ, Ma WL, Song YB, Guo QY, Wu QH, Zheng WL (2002) Detection of cell apoptosis by MTT assay. Di Yi Jun Yi Da Xue Xue Bao 22(3):262–263
13. Franke TF, Cantley LC (1997) Apoptosis. A bad kinase makes good. Nature 390(6656):116–117
14. Frasca G, Carbonaro V, Merlo S, Copani A, Sortino MA (2008) Integrins mediate beta-amyloid-induced cell-cycle activation and neuronal death. J Neurosci Res 86(2):350–355
15. Ghasemi R, Dargahi L, Haeri A, Moosavi M, Mohamed Z, Ahmadiani A (2013a) Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders. Mol Neurobiol 47(3):1045–1065
16. Ghasemi R, Haeri A, Dargahi L, Mohamed Z, Ahmadiani A (2013b) Insulin in the brain: sources, localization and functions. Mol Neurobiol 47(1):145–171
17. Ghasemi R, Zarifkar A, Rastegar K, Maghsoudi N, Moosavi M (2014) Insulin protects against Abeta-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption. Neuropharmacology 85C:113–120
18. Havrankova J, Roth J, Brownstein M (1978a) Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272(5656):827–829
19. Havrankova J, Schmechel D, Roth J, Brownstein M (1978b) Identification of insulin in rat brain. Proc Natl Acad Sci U S A 75(11):5737–5741
20. Hill J, Lesniak M, Pert C, Roth J (1986) Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience 17(4):1127–1138
21. Holscher C (2014) First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer’s disease. Alzheimers Dement 10(1 Suppl):S33–S37
22. Ivins KJ, Thornton PL, Rohn TT, Cotman CW (1999) Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. Neurobiol Dis 6(5):440–449
23. Kong J, Ren G, Jia N, Wang Y, Zhang H, Zhang W, Chen B, Cao Y (2013) Effects of nicorandil in neuroprotective activation of PI3K/AKT pathways in a cellular model of Alzheimer’s disease. Eur Neurol 70(3–4):233–241
24. Lee ER, Kim JY, Kang YJ, Ahn JY, Kim JH, Kim BW, Choi HY, Jeong MY, Cho SG (2006) Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis. Biochim Biophys Acta 1763(9):958–968
25. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW (1993) Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A 90(17):7951–7955
26. Nassif M, Hoppe J, Santin K, Frozza R, Zamin LL, Simao F, Horn AP, Salbego C (2007) Beta-amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3beta, and PTEN. Neurochem Int 50(1):229–235
27. Parihar MS, Hemnani T (2004) Alzheimer’s disease pathogenesis and therapeutic interventions. J Clin Neurosci 11(5):456–467
28. Paz K, Liu YF, Shorer H, Hemi R, LeRoith D, Quan M, Kanety H, Seger R, Zick Y (1999) Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function. J Biol Chem 274(40):28816–28822
29. Porter AG, Janicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6(2):99–104
30. Rickle A, Bogdanovic N, Volkman I, Winblad B, Ravid R, Cowburn RF (2004) Akt activity in Alzheimer’s disease and other neurodegenerative disorders. Neuroreport 15(6):955–959
31. Roskoski R Jr (2012a) ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res 66(2):105–143
32. Roskoski R Jr (2012b) MEK1/2 dual-specificity protein kinases: structure and regulation. Biochem Biophys Res Commun 417(1):5–10
33. Savage MJ, Lin YG, Ciallella JR, Flood DG, Scott RW (2002) Activation of c-Jun N-terminal kinase and p38 in an Alzheimer’s disease model is associated with amyloid deposition. J Neurosci 22(9):3376–3385
34. Schulingkamp R, Pagano T, Hung D, Raffa R (2000) Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci Biobehav Rev 24(8):855–872
35. Subramaniam S, Unsicker K (2010) ERK and cell death: ERK1/2 in neuronal death. FEBS J 277(1):22–29
36. Tanti JF, Jager J (2009) Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr Opin Pharmacol 9(6):753–762
37. Theberge JF, Mehdi MZ, Pandey SK, Srivastava AK (2003) Prolongation of insulin-induced activation of mitogen-activated protein kinases ERK 1/2 and phosphatidylinositol 3-kinase by vanadyl sulfate, a protein tyrosine phosphatase inhibitor. Arch Biochem Biophys 420(1):9–17
38. Townsend M, Mehta T, Selkoe DJ (2007) Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J Biol Chem 282(46):33305–33312
39. van Houten M, Posner BI, Kopriwa BM (1980) Insulin binding sites localized to nerve terminals in rat median eminence and arcuate nucleus. Science 207(4435):1081
40. Watson K, Fan GH (2005) Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1–42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Mol Pharmacol 67(3):757–765
41. Yamaguchi H, Wang HG (2001) The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 20(53):7779–7786
42. Zhao WQ, Alkon DL (2001) Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 177(1–2):125–134
43. Zhu X, Castellani RJ, Takeda A, Nunomura A, Atwood CS, Perry G, Smith MA (2001) Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the ‘two hit’ hypothesis. Mech Ageing Dev 123(1):39–46